ION440
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ION440, covering 2026-03-24 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS) [Phase 1, Phase 2]